Analyst's Notebook - Content
Recap.com
Signals Magazine
rDNA.com
RecapRx.com
RecapIP.com
Allicense
Alliance Trends 1992-2006
Title
Value of Biotech Out-licensing Deals with Pharma and Biotech
(
Slide 1 of 73
)
Description
Author
Recombinant Capital
NEXT--->
* Total value for each year was calculated by multiplying the number of deals with unknown value by the median announced deal value for that year, and adding the result to the total announced deal value.
The Analysts' Notebook is prepared by Deloitte Recap LLC’s analysts and consultants using
Recap.com
and
rDNA.com
data. For over 15 years Recap Consulting has provided clients with expert advice and in-depth analysis in the areas of alliance structuring and deal valuation.
Copyright ©
2010
Deloitte Recap LLC |
Privacy Policy
|
Contact
0